Alemtuzumab Intravenous and Antihemophilic Factor (Recombinant) (Advate)
Determining the interaction of Alemtuzumab Intravenous and Antihemophilic Factor (Recombinant) (Advate) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Antihemophilic Factor (Recombinant) (Afstyla)
- Alemtuzumab Intravenous-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Alemtuzumab Intravenous-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)
- Alemtuzumab Intravenous-Antihemophilic Factor (Recombinant) (Nuwiq)
- Alemtuzumab Intravenous-Antihemophilic Factor (Recombinant) (Recombinate)
- Alemtuzumab Intravenous-Antihemophilic Factor (Recombinant) (Xyntha)
- Antihemophilic Factor (Recombinant) (Advate)-Alenaze-D
- Antihemophilic Factor (Recombinant) (Advate)-Alendronate
- Antihemophilic Factor (Recombinant) (Advate)-Alendronate and cholecalciferol
- Antihemophilic Factor (Recombinant) (Advate)-Alendronate Effervescent Tablets
- Antihemophilic Factor (Recombinant) (Advate)-Alendronate Oral Solution
- Antihemophilic Factor (Recombinant) (Advate)-Alendronate Sodium